Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Miedema

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|May 6, 1989
Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortalityM Tersmette, J M Lange, R E de Goede, et al.
Nature Medicine|February 14, 1998
Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferationN G Pakker, D W Notermans, R J de Boer, et al.
The Journal of Clinical Investigation|November 1, 1994
Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmissionA B van't Wout, N A Kootstra, G A Mulder-Kampinga, et al.
The Journal of Infectious Diseases|September 9, 1999
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adultsD W Notermans, N G Pakker, D Hamann, et al.
Blood|July 13, 2000
T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapyD R Clark, S Repping, N G Pakker, et al.
Antiviral Therapy|June 22, 2001
Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trialN A Foudraine, S Jurriaans, G J Weverling, et al.
Blood|June 22, 2001
Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphomaD van Baarle, E Hovenkamp, M F Callan, et al.
The Journal of General Virology|August 1, 1996
Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1C A van Baalen, M R Klein, R C Huisman, et al.
The Journal of Experimental Medicine|April 1, 1995
Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomaticsM R Klein, C A van Baalen, A M Holwerda, et al.
The Journal of Clinical Investigation|December 1, 1985
Analysis of helper activity on pokeweed mitogen- and interleukin 2-driven immunoglobulin synthesis by neoplastic T4+ cellsF Miedema, J W van Oostveen, F G Terpstra, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|May 6, 1989
Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortalityM Tersmette, J M Lange, R E de Goede, et al.
Nature Medicine|February 14, 1998
Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferationN G Pakker, D W Notermans, R J de Boer, et al.
The Journal of Clinical Investigation|November 1, 1994
Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmissionA B van't Wout, N A Kootstra, G A Mulder-Kampinga, et al.
The Journal of Infectious Diseases|September 9, 1999
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adultsD W Notermans, N G Pakker, D Hamann, et al.
Blood|July 13, 2000
T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapyD R Clark, S Repping, N G Pakker, et al.
Antiviral Therapy|June 22, 2001
Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trialN A Foudraine, S Jurriaans, G J Weverling, et al.
Blood|June 22, 2001
Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphomaD van Baarle, E Hovenkamp, M F Callan, et al.
The Journal of General Virology|August 1, 1996
Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1C A van Baalen, M R Klein, R C Huisman, et al.
The Journal of Experimental Medicine|April 1, 1995
Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomaticsM R Klein, C A van Baalen, A M Holwerda, et al.
The Journal of Clinical Investigation|December 1, 1985
Analysis of helper activity on pokeweed mitogen- and interleukin 2-driven immunoglobulin synthesis by neoplastic T4+ cellsF Miedema, J W van Oostveen, F G Terpstra, et al.
Pageof 18